Literature DB >> 2930023

Cerebrospinal fluid analysis of rabid and vaccinia-rabies glycoprotein recombinant, orally vaccinated raccoons (Procyon lotor).

C A Hanlon1, E L Ziemer, A N Hamir, C E Rupprecht.   

Abstract

Cerebrospinal fluid obtained from clinically normal free-ranging raccoons was analyzed and compared with CSF obtained from raccoons vaccinated orally with vaccinia-rabies glycoprotein (V-RG) recombinant virus vaccine and subsequently challenged peripherally with street rabies virus, and CSF from naive, rabies virus challenge-exposed control raccoons. Significant differences were not found in CSF of free-ranging or V-RG recombinant virus vaccine recipient raccoons, and there was no evidence of CNS invasion by V-RG virus. The CSF of naive, rabies challenge-exposed control raccoons contained high numbers of lymphocytes and monocytes, compatible with rabies virus encephalitis. Although V-RG orally vaccinated challenge-exposed raccoons were protected from lethal rabies virus infection, a mild lymphocytic pleocytosis was evident at 90 days after challenge exposure.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2930023

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  2 in total

1.  The prevalence of interstitial nephritis and leptospirosis in 283 raccoons (Procyon lotor) from 5 different sites in the United States.

Authors:  A N Hamir; C A Hanlon; M Niezgoda; C E Rupprecht
Journal:  Can Vet J       Date:  2001-11       Impact factor: 1.008

Review 2.  Oral vaccination of wildlife using a vaccinia-rabies-glycoprotein recombinant virus vaccine (RABORAL V-RG®): a global review.

Authors:  Joanne Maki; Anne-Laure Guiot; Michel Aubert; Bernard Brochier; Florence Cliquet; Cathleen A Hanlon; Roni King; Ernest H Oertli; Charles E Rupprecht; Caroline Schumacher; Dennis Slate; Boris Yakobson; Anne Wohlers; Emily W Lankau
Journal:  Vet Res       Date:  2017-09-22       Impact factor: 3.683

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.